431 related articles for article (PubMed ID: 33582369)
1. Pre-existing T-cell immunity to SARS-CoV-2 in unexposed healthy controls in Ecuador, as detected with a COVID-19 Interferon-Gamma Release Assay.
Echeverría G; Guevara Á; Coloma J; Ruiz AM; Vasquez MM; Tejera E; de Waard JH
Int J Infect Dis; 2021 Apr; 105():21-25. PubMed ID: 33582369
[TBL] [Abstract][Full Text] [Related]
2. Broad T Cell Targeting of Structural Proteins After SARS-CoV-2 Infection: High Throughput Assessment of T Cell Reactivity Using an Automated Interferon Gamma Release Assay.
Brand I; Gilberg L; Bruger J; Garí M; Wieser A; Eser TM; Frese J; Ahmed MIM; Rubio-Acero R; Guggenbuehl Noller JM; Castelletti N; Diekmannshemke J; Thiesbrummel S; Huynh D; Winter S; Kroidl I; Fuchs C; Hoelscher M; Roider J; Kobold S; Pritsch M; Geldmacher C
Front Immunol; 2021; 12():688436. PubMed ID: 34093595
[TBL] [Abstract][Full Text] [Related]
3. IFN-γ
Vallejo A; Vizcarra P; Quereda C; Moreno A; Casado JL;
Eur J Clin Invest; 2021 Dec; 51(12):e13636. PubMed ID: 34164811
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 specific T-cell immunity in COVID-19 convalescent patients and unexposed controls measured by ex vivo ELISpot assay.
Cassaniti I; Percivalle E; Bergami F; Piralla A; Comolli G; Bruno R; Vecchia M; Sambo M; Colaneri M; Zuccaro V; Benazzo M; Robotti C; Calastri A; Maiorano E; Ferrari A; Cambiè G; Baldanti F
Clin Microbiol Infect; 2021 Jul; 27(7):1029-1034. PubMed ID: 33813122
[TBL] [Abstract][Full Text] [Related]
5. Clinical Performance of a Standardized Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Interferon-γ Release Assay for Simple Detection of T-Cell Responses After Infection or Vaccination.
Fernández-González M; Agulló V; Padilla S; García JA; García-Abellán J; Botella Á; Mascarell P; Ruiz-García M; Masiá M; Gutiérrez F
Clin Infect Dis; 2022 Aug; 75(1):e338-e346. PubMed ID: 34893816
[TBL] [Abstract][Full Text] [Related]
6. S Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit.
Nguyen-Contant P; Embong AK; Kanagaiah P; Chaves FA; Yang H; Branche AR; Topham DJ; Sangster MY
mBio; 2020 Sep; 11(5):. PubMed ID: 32978311
[TBL] [Abstract][Full Text] [Related]
7. A Pilot Study for the Evaluation of an Interferon Gamma Release Assay (IGRA) To Measure T-Cell Immune Responses after SARS-CoV-2 Infection or Vaccination in a Unique Cloistered Cohort.
Barreiro P; Sanz JC; San Román J; Pérez-Abeledo M; Carretero M; Megías G; Viñuela-Prieto JM; Ramos B; Canora J; Martínez-Peromingo FJ; Barba R; Zapatero A; Candel FJ
J Clin Microbiol; 2022 Mar; 60(3):e0219921. PubMed ID: 35020419
[TBL] [Abstract][Full Text] [Related]
8. Coordinated innate and T-cell immune responses in mild COVID-19 patients from household contacts of COVID-19 cases during the first pandemic wave.
Aiello A; Grossi A; Meschi S; Meledandri M; Vanini V; Petrone L; Casetti R; Cuzzi G; Salmi A; Altera AM; Pierelli L; Gualano G; Ascoli Bartoli T; Castilletti C; Agrati C; Girardi E; Palmieri F; Nicastri E; Di Rosa E; Goletti D
Front Immunol; 2022; 13():920227. PubMed ID: 35967321
[TBL] [Abstract][Full Text] [Related]
9. B and T cell response to SARS-CoV-2 vaccination in health care professionals with and without previous COVID-19.
Zollner A; Watschinger C; Rössler A; Farcet MR; Penner A; Böhm V; Kiechl SJ; Stampfel G; Hintenberger R; Tilg H; Koch R; Antlanger M; Kreil TR; Kimpel J; Moschen AR
EBioMedicine; 2021 Aug; 70():103539. PubMed ID: 34391087
[TBL] [Abstract][Full Text] [Related]
10. Novel T cell interferon gamma release assay (IGRA) using spike recombinant protein for COVID19 vaccine response and Nucleocapsid for SARS-Cov2 response.
Renaudineau Y; Abravanel F; Izopet J; Bost C; Treiner E; Congy N; Blancher A
Clin Immunol; 2022 Apr; 237():108979. PubMed ID: 35301104
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2-specific T cell responses: a comparative analysis between QuantiFERON SARS-CoV-2, T-SPOT.COVID, and an in-house Omicron ELISpot.
Mak WA; Visser W; Koeleman JGM; Ong DSY
J Virol Methods; 2024 Jun; 327():114949. PubMed ID: 38710307
[TBL] [Abstract][Full Text] [Related]
12. An evaluation of a FluoroSpot assay as a diagnostic tool to determine SARS-CoV-2 specific T cell responses.
Mangsbo SM; Havervall S; Laurén I; Lindsay R; Jernbom Falk A; Marking U; Lord M; Buggert M; Dönnes P; Christoffersson G; Nilsson P; Hober S; Phillipson M; Klingström J; Thålin C
PLoS One; 2021; 16(9):e0258041. PubMed ID: 34591918
[TBL] [Abstract][Full Text] [Related]
13. Humoral and T cell responses to SARS-CoV-2 reveal insights into immunity during the early pandemic period in Pakistan.
Masood KI; Qaiser S; Abidi SH; Khan E; Mahmood SF; Hussain A; Ghous Z; Imtiaz K; Ali N; Hasan M; Memon HA; Yameen M; Ali S; Baloch S; Lakhani G; Alves PM; Iqbal NT; Ahmed K; Iqbal J; Bhutta ZA; Hussain R; Rottenberg M; Simas JP; Veldhoen M; Ghias K; Hasan Z
BMC Infect Dis; 2023 Dec; 23(1):846. PubMed ID: 38041026
[TBL] [Abstract][Full Text] [Related]
14. Healthy donor T cell responses to common cold coronaviruses and SARS-CoV-2.
Woldemeskel BA; Kwaa AK; Garliss CC; Laeyendecker O; Ray SC; Blankson JN
J Clin Invest; 2020 Dec; 130(12):6631-6638. PubMed ID: 32966269
[TBL] [Abstract][Full Text] [Related]
15. Novel ELISA Protocol Links Pre-Existing SARS-CoV-2 Reactive Antibodies With Endemic Coronavirus Immunity and Age and Reveals Improved Serologic Identification of Acute COVID-19
Yuen RR; Steiner D; Pihl RMF; Chavez E; Olson A; Smith EL; Baird LA; Korkmaz F; Urick P; Sagar M; Berrigan JL; Gummuluru S; Corley RB; Quillen K; Belkina AC; Mostoslavsky G; Rifkin IR; Kataria Y; Cappione AJ; Gao W; Lin NH; Bhadelia N; Snyder-Cappione JE
Front Immunol; 2021; 12():614676. PubMed ID: 33897682
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 specific memory T cell epitopes identified in COVID-19-recovered subjects.
Zhao J; Wang L; Schank M; Dang X; Lu Z; Cao D; Khanal S; Nguyen LN; Nguyen LNT; Zhang J; Zhang Y; Adkins JL; Baird EM; Wu XY; Ning S; Gazzar ME; Moorman JP; Yao ZQ
Virus Res; 2021 Oct; 304():198508. PubMed ID: 34329696
[TBL] [Abstract][Full Text] [Related]
17. Development of an in-house SARS-CoV-2 interferon-gamma ELISpot and plate reader-free spot detection method.
Mak WA; Koeleman JGM; Ong DSY
J Virol Methods; 2022 Feb; 300():114398. PubMed ID: 34863782
[TBL] [Abstract][Full Text] [Related]
18. Interferon-gamma release assays outcomes in healthy subjects following BNT162b2 mRNA COVID-19 vaccination.
Kurteva E; Vasilev G; Tumangelova-Yuzeir K; Ivanova I; Ivanova-Todorova E; Velikova T; Kyurkchiev D
Rheumatol Int; 2022 Mar; 42(3):449-456. PubMed ID: 35059799
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of QuantiFERON SARS-CoV-2 research use only assay and characterization of the CD4
Aiello A; Coppola A; Vanini V; Petrone L; Cuzzi G; Salmi A; Altera AMG; Tortorella C; Gualano G; Gasperini C; Scolieri P; Beccacece A; Vita S; Bruzzese V; Lorenzetti R; Palmieri F; Nicastri E; Goletti D
Int J Infect Dis; 2022 Sep; 122():841-849. PubMed ID: 35878802
[TBL] [Abstract][Full Text] [Related]
20. Detection of Serum Cross-Reactive Antibodies and Memory Response to SARS-CoV-2 in Prepandemic and Post-COVID-19 Convalescent Samples.
Shrwani K; Sharma R; Krishnan M; Jones T; Mayora-Neto M; Cantoni D; Temperton NJ; Dobson SL; Subramaniam K; McNamara PS; Cunliffe NA; Turtle L; Zhang Q
J Infect Dis; 2021 Oct; 224(8):1305-1315. PubMed ID: 34161567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]